Ryan Gentzler MD

Dr. Ryan Gentzler received his MD degree from Temple University School of Medicine and completed his internal medicine internship and residency at Thomas Jefferson University Hospital. He also earned a master’s degree in pharmacology during his residency with a focus on clinical investigation supported by the NIH K30 Clinical Research Curriculum Award. He completed his hematology/oncology fellowship at Northwestern University.

Dr. Gentzler’s clinical focus is the treatment of patients with lung cancer and other thoracic malignancies. His research is centered around the development of novel therapies for lung cancer. His goal is to contribute meaningful research that leads to improvements in the curability, survival, and quality of life of patients with lung cancer.

He is an active investigator on many active clinical trials, serves as the director of the Thoracic Oncology Clinical Research Program at UVA, and chairs the UVA Cancer Center’s Lung Cancer Translational Research Team. Dr. Gentzler is also the director of the UVA Cancer Center Protocol Review Committee, which provides scientific review and oversight of cancer research conducted at UVA. On a national level, he has leadership roles in the NCI Experimental Therapeutics Clinical Trials Network (ETCTN) and Thoracic Clinical Trials Working Group for the Hoosier Cancer Research Network (HCRN). He is also an active member of the ECOG-ACRIN cooperative group.